Sort By:

Knee Pain Study

Currently, the therapies to treat knee pain from osteoarthritis are limited. Most current treatments are only designed to relieve pain and reduce the disability caused by bone and cartilage degeneration. Drug therapies target the symptoms but not the cause of the disease. Rochester Clinical Research is currently enrolling individuals between the ages of 40 – 80 for a research study of a new study drug aimed at reversing the degenerative changes in your cartilage and bone. The study drug would be administered through a single injection in the knee with the most pain.

View Trial Details
Ages 40 - 80
Compensation* $675
Study Topics Knee Pain

*Compensation for time and travel may be available to those who qualify.

Oral Migraine Relief Medication

This is a 15 week long research study for people who get 2-8 migraines a month. This is an oral medication that could potentially reduce migraine symptoms once a migraine begins.

View Trial Details
Ages 18 - 65
Compensation* $490
Study Topics Migraines

*Compensation for time and travel may be available to those who qualify.

Knee Pain

Researching an investigational drug administered orally once daily in patients with knee osteoarthritis. The drug is aimed at reducing cartilaginous degradation and hopefully improve pain and function in the arthritic knee.

View Trial Details
Ages 40 - 75
Compensation* $575
Study Topics Knee Pain

*Compensation for time and travel may be available to those who qualify.

Oral Migraine Medication

Rochester Clinical Research is currently enrolling for a 60 week long research study to evaluate the efficiency of a daily oral migraine investigational medication. 16 visits to Rochester Clinical Research will be a requirement throughout the study.

View Trial Details
Ages 18 - 80
Study Topics Migraines